ConductScience.org, home

Paper6327770

Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.

Waldmann TA and 9 others. J Clin Invest, 1984. Cited by 219 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. Papers, record 6327770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6327770

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
PubMed
Journal
J Clin Invest
PubMed
Year
1984
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
219
iCite
Relative citation ratio, by iCite
5.17
iCite
Revised in PubMed
2018-11-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Waldmann TAT A
2Greene WCW C
3Sarin PSP S
4Saxinger CC
5Blayney DWD W
6Blattner WAW A
7Goldman CKC K
8Bongiovanni KK
9Sharrow SS
10Depper JMJ M

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DeltaretrovirusMajor topic
LeukemiaMajor topic
LymphomaMajor topic
Receptors, ImmunologicMajor topic
RetroviridaeMajor topic
Sezary SyndromeMajor topic
T-LymphocytesMajor topic
Adult
Antibodies, Monoclonal
Antibody Formation
Humans
Phenotype
Receptors, Interleukin-2
Reference Values

Source PubMed

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00924170Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell LeukemiaBackground

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1181,845Selective in vitro growth of T lymphocytes from normal human bone marrows.Science1976https://conductscience.org/library/papers/181845PubMed
26,982,476Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6982476PubMed
36,815,536A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor.Nature1982https://conductscience.org/library/papers/6815536PubMed
46,293,176Identification of HTLV p19 specific natural human antibodies by competition with monoclonal antibody.Virology1982https://conductscience.org/library/papers/6293176PubMed
56,984,061Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens.J Exp Med1982https://conductscience.org/library/papers/6984061PubMed
66,600,519Isolation and transmission of human retrovirus (human t-cell leukemia virus).Science1983https://conductscience.org/library/papers/6600519PubMed
76,300,254Epidemiology of human T-cell leukemia/lymphoma virus.J Infect Dis1983https://conductscience.org/library/papers/6300254PubMed
86,308,290The human T-cell leukemia-lymphoma virus in the southeastern United States.JAMA1983https://conductscience.org/library/papers/6308290PubMed
96,195,529Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor.Nature1983https://conductscience.org/library/papers/6195529PubMed
106,417,659Characterization of the human receptor for T-cell growth factor.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6417659PubMed
116,764,996Progress in adult T cell leukemia research.Acta Pathol Jpn1982https://conductscience.org/library/papers/6764996PubMed
12794,413The T cell dependence of B cell differentiation induced by pokeweed mitogen.J Immunol1976https://conductscience.org/library/papers/794413PubMed
13301,762Adult T-cell leukemia: clinical and hematologic features of 16 cases.Blood1977https://conductscience.org/library/papers/301762PubMed
14304,175Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.N Engl J Med1978https://conductscience.org/library/papers/304175PubMed
15306,907Effect of adult T-cell leukemia cells on pokeweed mitogen-induced normal B-cell differentiation.Clin Immunol Immunopathol1978https://conductscience.org/library/papers/306907PubMed
16101,844The suppressor-cell network in cancer (first of two parts).N Engl J Med1978https://conductscience.org/library/papers/101844PubMed
17310,966An Lyt differentiated thymocyte subpopulation detected by flow microfluorometry.Nature1979https://conductscience.org/library/papers/310966PubMed
18311,642Cutaneous T-cell lymphoma: neoplasm of T cells with helper activity.Blood1979https://conductscience.org/library/papers/311642PubMed
19313,290Suppressor cell population in Sézary syndrome.Clin Immunol Immunopathol1979https://conductscience.org/library/papers/313290PubMed
20315,070Separation of functional subsets of human T cells by a monoclonal antibody.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/315070PubMed

See all 41 references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 219 citations.

PMIDTitleJournalYearIn PapersSource
40,680,114BLIMP1 negatively regulates IL-2 signaling in T cells.Sci Adv2025https://conductscience.org/library/papers/40680114PubMed
32,547,515Novel Treatments of Adult T Cell Leukemia Lymphoma.Front Microbiol2020https://conductscience.org/library/papers/32547515PubMed
32,275,165
90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma.
Cancer Biother Radiopharm2020https://conductscience.org/library/papers/32275165PubMed
28,087,047Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38.Cell Immunol2017https://conductscience.org/library/papers/28087047PubMed
26,438,86690Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26438866PubMed
26,350,263Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.Clin Cancer Res2016https://conductscience.org/library/papers/26350263PubMed
25,733,162Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.Br J Haematol2015https://conductscience.org/library/papers/25733162PubMed
25,267,440Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.Clin Immunol2014https://conductscience.org/library/papers/25267440PubMed
23,352,221Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.Immunity2013https://conductscience.org/library/papers/23352221PubMed
21,993,874Antibody therapy for Adult T-cell leukemia-lymphoma.Int J Hematol2011https://conductscience.org/library/papers/21993874PubMed
21,951,590An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells.Cancer Sci2012https://conductscience.org/library/papers/21951590PubMed
18,948,574Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25.Blood2009https://conductscience.org/library/papers/18948574PubMed
18,569,641Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.Leuk Lymphoma2008https://conductscience.org/library/papers/18569641PubMed
18,475,497Biological significance of soluble IL-2 receptor.Mediators Inflamm1993https://conductscience.org/library/papers/18475497PubMed
16,569,769Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25.Blood2006https://conductscience.org/library/papers/16569769PubMed
12,692,230Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.J Virol2003https://conductscience.org/library/papers/12692230PubMed
11,053,100Advances in interleukin 2 receptor targeted treatment.Ann Rheum Dis2000https://conductscience.org/library/papers/11053100PubMed
9,624,582
Interleukin-1 alpha increases the preferential cytotoxicity of an interleukin-2-diphtheria toxin fusion protein against neoplastic lymphocytes from patients with the Sezary syndrome compared to normal lymphocytes.
J Clin Immunol1998https://conductscience.org/library/papers/9624582PubMed
8,197,160A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8197160PubMed
7,860,737The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients.J Clin Invest1995https://conductscience.org/library/papers/7860737PubMed

See all 35 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL23,558PubTator's text mininghttps://conductscience.org/library/genes/3558

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6327770

GET https://conductscience.org/api/papers/v1/6327770/references?page=2